Clinical Trial Update: Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery [NA]

View source ↗

Summary

A clinical trial is evaluating atropine 0.05% eye drops to control myopia progression after pediatric cataract surgery with intraocular lens implantation; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Myopia Progression

Drugs mentioned

• Atropine 0.05% ophthalmic solution (Atropine)

Snippet

Sponsor: Cairo University | Conditions: Pediatric Cataract, IOL Implantation | NA | Status: NOT_YET_RECRUITING